This week, The Long Run with Luke Timmerman explored how researchers are developing long-lasting antibodies to treat immune disorders, a shift that could reduce treatment burden for patients who currently require frequent infusions. Cameron Turtle discussed the scientific and commercial challenges of engineering antibodies with extended half-lives, touching on everything from manufacturing complexity to the competitive landscape of biologics. The conversation highlighted a broader tension in biotech: how to balance scientific innovation with the practical realities of bringing new therapies to market.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top the long run with luke timmerman podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in The Long Run with Luke Timmerman (Sep 7 - Sep 13, 2026)
1 episode · Sep 7 – Sep 13
This Week in The Long Run with Luke Timmerman (Aug 24 - Aug 30, 2026)
1 episode · Aug 24 – Aug 30
This Week in The Long Run with Luke Timmerman (Aug 10 - Aug 16, 2026)
1 episode · Aug 10 – Aug 16
This Week in The Long Run with Luke Timmerman (Jul 27 - Aug 2, 2026)
1 episode · Jul 27 – Aug 2
This Week in The Long Run with Luke Timmerman (Jul 13 - Jul 19, 2026)
1 episode · Jul 13 – Jul 19
This Week in The Long Run with Luke Timmerman (Jun 29 - Jul 5, 2026)
1 episode · Jun 29 – Jul 5
This Week in The Long Run with Luke Timmerman (Jun 15 - Jun 21, 2026)
1 episode · Jun 15 – Jun 21
This Week in The Long Run with Luke Timmerman (Jun 1 - Jun 7, 2026)
1 episode · Jun 1 – Jun 7
This Week in The Long Run with Luke Timmerman (May 18 - May 24, 2026)
1 episode · May 18 – May 24
This Week in The Long Run with Luke Timmerman (May 4 - May 10, 2026)
1 episode · May 4 – May 10